133 related articles for article (PubMed ID: 25188725)
1. Dual glutathione-S-transferase-θ1 and -μ1 gene deletions determine imatinib failure in chronic myeloid leukemia.
Davies A; Giannoudis A; Zhang JE; Austin G; Wang L; Holyoake TL; Müller MC; Foroni L; Kottaridis PD; Pirmohamed M; Clark RE
Clin Pharmacol Ther; 2014 Dec; 96(6):694-703. PubMed ID: 25188725
[TBL] [Abstract][Full Text] [Related]
2. Influence of genetic polymorphisms in glutathione-S-transferases gene in response to imatinib among Brazilian patients with chronic myeloid leukemia.
Delmond KA; Delleon H; Goveia RM; Teixeira TM; Abreu DC; Mello-Andrade F; Reis AADS; Silva DME; Barbosa ADP; Tavares RS; Anunciação CE; Silveira-Lacerda E
Mol Biol Rep; 2021 Mar; 48(3):2035-2046. PubMed ID: 33709282
[TBL] [Abstract][Full Text] [Related]
3. Effect of interaction of glutathione S-transferases (T1 and M1) on the hematologic and cytogenetic responses in chronic myeloid leukemia patients treated with imatinib.
Kassogue Y; Quachouh M; Dehbi H; Quessar A; Benchekroun S; Nadifi S
Med Oncol; 2014 Jul; 31(7):47. PubMed ID: 24913811
[TBL] [Abstract][Full Text] [Related]
4. Association of GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms with clinical response to imatinib mesylate treatment among Malaysian chronic myeloid leukaemia patients.
Makhtar SM; Husin A; Baba AA; Ankathil R
J Genet; 2017 Sep; 96(4):633-639. PubMed ID: 28947711
[TBL] [Abstract][Full Text] [Related]
5. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response.
Rostami G; Assad D; Ghadyani F; Hamid M; Karami A; Jalaeikhoo H; Kalahroodi RA
Mol Genet Genomic Med; 2019 Jul; 7(7):e00717. PubMed ID: 31111691
[TBL] [Abstract][Full Text] [Related]
6. Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia.
Sailaja K; Surekha D; Rao DN; Rao DR; Vishnupriya S
Asian Pac J Cancer Prev; 2010; 11(2):461-4. PubMed ID: 20843134
[TBL] [Abstract][Full Text] [Related]
7. Role of glutathione-S-transferase M1 (GSTM1) and T1 (GSTT1) genes in the development and progress of chronic myeloid leukemia and in the formation of response to imatinib therapy.
Ovsepyan VA; Luchinin AS; Zagoskina TP
Bull Exp Biol Med; 2014 Dec; 158(2):242-5. PubMed ID: 25432281
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase gene polymorphic sequence variations: Association with risk and response to Imatinib among Chronic Myeloid Leukemia patients of Kashmir.
Baba SM; Shah ZA; Pandith AA; Geelani SA; Mir MM; Bhat JR; Gul A; Bhat GM
Int J Lab Hematol; 2021 Oct; 43(5):1000-1008. PubMed ID: 33470551
[TBL] [Abstract][Full Text] [Related]
9. Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients.
Elghannam DM; Ibrahim L; Ebrahim MA; Azmy E; Hakem H
Hematology; 2014 Apr; 19(3):123-8. PubMed ID: 23683876
[TBL] [Abstract][Full Text] [Related]
10. GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.
Weich N; Ferri C; Moiraghi B; Bengió R; Giere I; Pavlovsky C; Larripa IB; Fundia AF
Cancer Epidemiol; 2016 Oct; 44():16-21. PubMed ID: 27454607
[TBL] [Abstract][Full Text] [Related]
11. The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia.
Giannoudis A; Wang L; Jorgensen AL; Xinarianos G; Davies A; Pushpakom S; Liloglou T; Zhang JE; Austin G; Holyoake TL; Foroni L; Kottaridis PD; Müller MC; Pirmohamed M; Clark RE
Blood; 2013 Jan; 121(4):628-37. PubMed ID: 23223357
[TBL] [Abstract][Full Text] [Related]
12. Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?
Bedewy AM; El-Maghraby SM
Hematology; 2013 Jul; 18(4):211-6. PubMed ID: 23394475
[TBL] [Abstract][Full Text] [Related]
13. PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia.
Wolff NC; Veach DR; Tong WP; Bornmann WG; Clarkson B; Ilaria RL
Blood; 2005 May; 105(10):3995-4003. PubMed ID: 15657179
[TBL] [Abstract][Full Text] [Related]
14. Genetic Polymorphism of GSTP1, GSTM1 and GSTT1 Genes and Susceptibility to Chronic Myeloid Leukaemia.
Idris HM; Elderdery AY; Khalil HB; Mills J
Asian Pac J Cancer Prev; 2020 Feb; 21(2):499-503. PubMed ID: 32102530
[TBL] [Abstract][Full Text] [Related]
15. Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitors.
Marcé S; Zamora L; Cabezón M; Xicoy B; Boqué C; Fernández C; Grau J; Navarro JT; Fernández de Sevilla A; Ribera JM; Feliu E; Millá F;
Med Clin (Barc); 2013 Aug; 141(3):95-9. PubMed ID: 23433665
[TBL] [Abstract][Full Text] [Related]
16. PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase.
Alonso-Dominguez JM; Grinfeld J; Alikian M; Marin D; Reid A; Daghistani M; Hedgley C; O'Brien S; Clark RE; Apperley J; Foroni L; Gerrard G
Am J Hematol; 2015 Jan; 90(1):20-6. PubMed ID: 25250944
[TBL] [Abstract][Full Text] [Related]
17. Association Between Glutathione-S-Transferase Gene Polymorphisms and Responses to Tyrosine Kinase Inhibitor Treatment in Patients with Chronic Myeloid Leukemia: A Meta-analysis.
Lee N; Park SM; Yee J; Yoon HY; Han JM; Gwak HS
Target Oncol; 2020 Feb; 15(1):47-54. PubMed ID: 31974831
[TBL] [Abstract][Full Text] [Related]
18. Molecular monitoring of response to imatinib (Glivec) in chronic myeloid leukemia patients: experience at a tertiary care hospital in Saudi Arabia.
Khalil SH; Abu-Amero KK; Al Mohareb F; Chaudhri NA
Genet Test Mol Biomarkers; 2010 Feb; 14(1):67-74. PubMed ID: 19943786
[TBL] [Abstract][Full Text] [Related]
19. Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy.
Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G
Haematologica; 2013 Feb; 98(2):193-200. PubMed ID: 22875622
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia.
He HR; Zhang XX; Sun JY; Hu SS; Ma Y; Dong YL; Lu J
Tumour Biol; 2014 Jun; 35(6):6119-25. PubMed ID: 24659449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
